Mounting Applications of Capsules in Antibiotic and Antibacterial and Anti-inflammatory Drugs Drives the Enteric Coated and Controlled Release Tablets and Capsules Market Growth

Wed, 14 October 2020 5:51

Bacterial vaginosis (BV) is an overgrowth of typical bacteria in the vagina. It is extremely prevalent in the U.S. As per the CDC, over 22 million women between the ages of 14–49 are suffering from bacterial vaginosis in the U.S. Globally, BV is highly prevalent in the developing countries, including Asia-Pacific, Latin America, and the Middle East and Africa, which is further driving the antibiotic and antibacterial drug segment growth. Moreover, gelatin and HPMC are extensively used for coating the antibiotic and antibacterial drug tablets and capsules as it extends the shelf life, prevents contamination, and ensures drug stability.

In the last few years, the prevalence of cardiovascular diseases and inflammatory diseases, such as autoimmune diseases, asthma, coeliac disease, glomerulonephritis, allergy, reperfusion injury, hepatitis, inflammatory bowel disease, and transplant rejection, is increasing at a concerning rate due to hereditary purposes and sedentary lifestyle. Asthma is one of the most common non-communicable diseases, which has subsequently increased the consumption of anti-inflammatory drugs by seven-folds. As per the Global Asthma Network (GAN) and the study conducted by the Global Burden of Disease (GBD), in 2016, over 39.4 million people had asthma across the globe.

Got questions about your regional growth of

Enteric Coated and Controlled Release Tablets and Capsules Market?

Just drop us a line or call on +1 646 480 7505

Europe’s Enteric-Coated and Controlled-Release Tablets and Capsules Market to Grow with the Highest CAGR of 7.3%

Europe’s enteric-coated and controlled-release tablets and capsules market is largely driven by the increasing consumption of antibiotic and antibacterial drugs, antacids, and other anti-inflammatory medications. As per the ECDC, in Europe, over 42,844 people suffered from the influenza virus during 2018–2019. Thereby, the rising prevalence of infectious diseases in the U.K., Norway, Ireland, Portugal, and Denmark, is subsequently boosting the market growth.

Key Highlights

  • The enteric coated and controlled release tablets and capsules market was valued at USD 45.20 million in 2019 and is expected to grow with a CAGR of 6.6%
  • The gelatin capsules segment is projected to grow with a significant CAGR of 7.3% on account of the increasing prevalence of severe and life-threatening diseases, rising healthcare expenditure, and rapidly growing consumption of medicines for several treatments
  • The vitamins and dietary supplement segment dominates the application segment and was valued at USD 8.87 million 2019
  • North America holds the largest market share in the enteric and changed release capsules market

Enteric Coated and Controlled Release Tablets and Capsules Market: Segmentation

By Type

  • Tablets
    • Gelatin Coating
    • Hydroxypropyl Methylcellulose (HPMC) Coating
  • Capsules
    • Gelatin
    • Hydroxypropyl Methylcellulose (HPMC)

By Application

  • Antibiotic and Antibacterial Drug
  • Vitamins and Dietary Supplement
  • Proton Pump Inhibitors
  • Anti-Inflammatory Drugs
  • Cardiovascular Therapy Drug
  • Neurological Drug

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Central and South America and the Caribbean
  • The MiddleEast and Africa

" Crucial Insights The Report Provides:"

* Known and Unknown Adjacencies Influencing the Growth of Market

* Explorable Revenue Sources

* Customer Behaviour Analysis

* Target Partners

* Customized Geographical Data Based on Customers as well as Competitors

* Analysis of Market Size and CAGR between the Forecast Periods

View Full Report Buy This Report Now